Multivariate Cox regression model of EFS
| Variable* . | Univariate analyses . | Multivariate model 1 . | Multivariate model 2 . | ||||||
|---|---|---|---|---|---|---|---|---|---|
| HR . | 95% CI . | P . | HR . | 95% CI . | P† . | HR . | 95% CI . | P† . | |
| Age at diagnosis (continuous, years) | 1.24 | 1.10-1.39 | .001 | ||||||
| At diagnosis | .001 | ||||||||
| <13 | 1 | ||||||||
| ≥13 | 7.12 | 2.19-23.17 | |||||||
| Gender | .349 | ||||||||
| Female | 1 | ||||||||
| Male | 1.69 | ||||||||
| Ethnicity | .160 | ||||||||
| Non-Hispanic | 1 | ||||||||
| Hispanic | 3.42 | 0.44-26.31 | |||||||
| Trisomy 21 | .470 | ||||||||
| Absent | 1 | ||||||||
| Present | 1.82 | 0.40-8.20 | |||||||
| NCI/Rome risk | .001 | .016 | .010 | ||||||
| Standard | 1 | 1 | 1 | ||||||
| High | 7.77 | 1.72-35.07 | 5.60 | 1.14-27.34 | 5.96 | 1.25-28.32 | |||
| WBC (per μL), continuous | 4.83 | 2.14-10.90 | <.001 | ||||||
| WBC (per μL) | .008 | ||||||||
| <50 000 | 1 | ||||||||
| ≥50 000 | 4.87 | 1.63-14.51 | |||||||
| Cytogenetics | .044 | ||||||||
| Neutral | 1 | ||||||||
| Favorable | 0.20 | 0.02-1.53 | |||||||
| Unfavorable | 6.90 | 0.80-59.75 | |||||||
| Obese | .061 | ||||||||
| No | 1 | ||||||||
| Yes | 2.95 | 0.99-8.80 | |||||||
| Weight category | .045 | .012 | .081 | ||||||
| Lean | 1 | 1 | 1 | ||||||
| Overweight | 3.78 | 0.84-16.91 | 7.70 | 1.37-43.12 | 5.65 | 1.17-27.30 | |||
| Obese | 4.31 | 1.22-15.29 | 6.65 | 1.40-31.63 | 2.57 | 0.70-9.36 | |||
| Weight change during induction | .011 | ||||||||
| Gain | 1 | ||||||||
| Loss | 4.57 | 1.26-16.63 | |||||||
| End-induction MRD (%), continuous | —‡ | <.001 | —‡ | <.001 | |||||
| End-induction MRD | .006 | .045 | |||||||
| Negative | 1 | 1 | |||||||
| Positive | 4.72 | 1.54-14.45 | 3.48 | 1.00-12.12 | |||||
| Variable* . | Univariate analyses . | Multivariate model 1 . | Multivariate model 2 . | ||||||
|---|---|---|---|---|---|---|---|---|---|
| HR . | 95% CI . | P . | HR . | 95% CI . | P† . | HR . | 95% CI . | P† . | |
| Age at diagnosis (continuous, years) | 1.24 | 1.10-1.39 | .001 | ||||||
| At diagnosis | .001 | ||||||||
| <13 | 1 | ||||||||
| ≥13 | 7.12 | 2.19-23.17 | |||||||
| Gender | .349 | ||||||||
| Female | 1 | ||||||||
| Male | 1.69 | ||||||||
| Ethnicity | .160 | ||||||||
| Non-Hispanic | 1 | ||||||||
| Hispanic | 3.42 | 0.44-26.31 | |||||||
| Trisomy 21 | .470 | ||||||||
| Absent | 1 | ||||||||
| Present | 1.82 | 0.40-8.20 | |||||||
| NCI/Rome risk | .001 | .016 | .010 | ||||||
| Standard | 1 | 1 | 1 | ||||||
| High | 7.77 | 1.72-35.07 | 5.60 | 1.14-27.34 | 5.96 | 1.25-28.32 | |||
| WBC (per μL), continuous | 4.83 | 2.14-10.90 | <.001 | ||||||
| WBC (per μL) | .008 | ||||||||
| <50 000 | 1 | ||||||||
| ≥50 000 | 4.87 | 1.63-14.51 | |||||||
| Cytogenetics | .044 | ||||||||
| Neutral | 1 | ||||||||
| Favorable | 0.20 | 0.02-1.53 | |||||||
| Unfavorable | 6.90 | 0.80-59.75 | |||||||
| Obese | .061 | ||||||||
| No | 1 | ||||||||
| Yes | 2.95 | 0.99-8.80 | |||||||
| Weight category | .045 | .012 | .081 | ||||||
| Lean | 1 | 1 | 1 | ||||||
| Overweight | 3.78 | 0.84-16.91 | 7.70 | 1.37-43.12 | 5.65 | 1.17-27.30 | |||
| Obese | 4.31 | 1.22-15.29 | 6.65 | 1.40-31.63 | 2.57 | 0.70-9.36 | |||
| Weight change during induction | .011 | ||||||||
| Gain | 1 | ||||||||
| Loss | 4.57 | 1.26-16.63 | |||||||
| End-induction MRD (%), continuous | —‡ | <.001 | —‡ | <.001 | |||||
| End-induction MRD | .006 | .045 | |||||||
| Negative | 1 | 1 | |||||||
| Positive | 4.72 | 1.54-14.45 | 3.48 | 1.00-12.12 | |||||